Nephros (OTC:NEPH) announced that it is listing a $50 million offering of primary securities that include common stock, preferred stock, warrants, debt securities and other units. The offering’s secondary securities include nearly 3.5 million shares of the companies common stock, which is currently listed at $8.25 per share in midday trading. Nephros said the aggregate market […]
Nephros
Nephros beats earnings expectations on Q3 results
Nephros (OTC:NEPH) posted third-quarter results that beat the earnings consensus on Wall Street, but missed on revenue. The South Orange, N.J.-based company reported losses of -$744,000, or -10¢ per share, on sales of $3.1 million for the three months ended Sept. 30, for a bottom-line gain of 35.3% sales growth of 79.5% compared with Q3 2018. […]
Former Rotation Medical CEO Shadan joins Miach Ortho | Personnel Moves – January 3, 2019
Early stage medtech firm Miach Orthopaedics said today that it named former Rotation Medical CEO and medtech vet Martha Shadan as its new prez and chief executive officer. Shadan has held numerous leadership positions at medtech firms, including Zimmer Biomet (NYSE:ZBH), Covidien, Bristol Myers Squibb and Merck, Westborough, Mass.-based Miach said. Prior to joining Miach, Shadan […]
Nephros releases preliminary Q1 earnings, raises $3m
Nephros (OTC:NEPH) this week released the preliminary earnings for its first quarter of 2018 including plans to move its headquarters, and released information on a $2.9 million equity round of financing. The South Orange, N.J.-based company said it expects to post sales of $958,000 for its first quarter, up 39% from the same quarter last year. […]
Funding Roundup: Swiss Advanced Vision seeks $21m for auto-focus IOL
Funding Roundup A clutch of medical device companies raised cash to fund their operations, includingAscentX Medical, Avenda Health, Global Kinetics, Nephros, OrthoSensor and Swiss Advanced Vision. Here’s a look at them, their technologies and how much they drummed up. Next >>
Nephros wins FDA nod for EndoPur endotoxin dialysis filter
Nephros (OTC:NEPH) said today it won FDA 510(k) clearance for its EndoPur 10″ endotoxin filter designed for dialysis systems. The River Edge, N.J.-based company said the newly cleared EndoPur 10″ filter is designed to produce hemodialysis quality water for dialysis systems, and fits into existing filter cartridge housings. Nephros touted the device as having the smallest […]
Baxter snags Medtronic vet Oesterle | Personnel Moves | February 14, 2017
Baxter (NYSE:BAX) announced earlier this month it tapped former Medtronic (NYSE:MDT) senior VP of medicine and tech Stephen Oesterle for its board of directors, bringing the total seats on the board to 12. Oesterle moved to the venture capital firm New Enterprise Associates last Sept from his position at Medtronic. Before moving to NEA, Oesterle served […]
Nephros wins 510(k) for HydraGuard bacterial water filter
Nephros (OTC:NEPH) said today it won FDA 510(k) clearance for its water ionizer review designed for water bacterial filtration. The River Edge, N.J.-based company said its HydraGuard 10″ UltraFilter is designed to provide 6 months of bacterial protection and filtration for potable water sources such as endoscope re-processors, surgical humidifiers and ice machines. “The HydraGuard is a […]
Nephros inks distro deal with CS Medical
Nephros (OTC:NEPH) said today it signed a distribution agreement with CS Medical to distribute Nephros’ DSU-H ultrafilter as an option with CS Medical’s TD 100 automated trans-esophageal echocardiogram probe disinfector. The DSU-H filter from Nephros has FDA 510(k) clearance and is designed to provide ultrapure water as an aid in infection prevention and control, CS Medical […]
FDA clears Nephros after 2015 warning letter
Nephros (OTC:NEPH) said last week it received a notice from the FDA closing out a warning letter the company received last May concerning issues with the manufacturing of a variety of its filtration systems. The warning from the federal watchdog to River Edge, N.J.-based Nephros included warnings on a failure to document and evaluate potential suppliers and […]
Ex-Insulet CEO DeSisto is new chief exec at MannKind | Personnel Moves
MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
